Literature DB >> 18957715

1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization.

Kristen L Zakian1, Amita Shukla-Dave, Ellen Ackerstaff, Hedvig Hricak, Jason A Koutcher.   

Abstract

Proton Magnetic Resonance Spectroscopic Imaging (MRSI) permits a non-invasive assessment of metabolites in the prostate gland. This article reviews the assessment of choline-containing compounds, citrate, and polyamines as markers for prostate tumor detection and aggressiveness.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18957715     DOI： 10.3233/cbm-2008-44-508

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN： 1574-0153            Impact factor:   4.388


  10 in total

1.  Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer.

Authors:  Tristan Barrett; Hebert Alberto Vargas; Oguz Akin; Debra A Goldman; Hedvig Hricak
Journal:  Radiology       Date:  2012-04-02       Impact factor: 11.105

Review 2.  Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.

Authors:  Stavroula Kyriazi; Stan B Kaye; Nandita M deSouza
Journal:  Nat Rev Clin Oncol       Date:  2010-04-13       Impact factor: 66.675

3.  Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.

Authors:  Jeffrey R Shuster; Raymond S Lance; Dean A Troyer
Journal:  BMC Clin Pathol       Date:  2011-12-21

4.  Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.

Authors:  Elin Thysell; Izabella Surowiec; Emma Hörnberg; Sead Crnalic; Anders Widmark; Annika I Johansson; Pär Stattin; Anders Bergh; Thomas Moritz; Henrik Antti; Pernilla Wikström
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

5.  Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.

Authors:  Lukasz Matulewicz; Jacobus F A Jansen; Louisa Bokacheva; Hebert Alberto Vargas; Oguz Akin; Samson W Fine; Amita Shukla-Dave; James A Eastham; Hedvig Hricak; Jason A Koutcher; Kristen L Zakian
Journal:  J Magn Reson Imaging       Date:  2013-11-15       Impact factor: 4.813

Review 6.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.

Authors:  Yu Xuan Kitzing; Adilson Prando; Celi Varol; Gregory S Karczmar; Fiona Maclean; Aytekin Oto
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

7.  Time point-independent tumor positivity of 68Ga-PSMA-PET/CT pre- and post-biopsy in high-risk prostate cancer.

Authors:  Sijuan Zou; Shuang Song; Jianyuan Zhou; Bo Yu; Dong Kuang; Zhihua Wang; Xiaohua Zhu
Journal:  Ann Nucl Med       Date:  2022-04-01       Impact factor: 2.258

Review 8.  MRS-based Metabolomics in Cancer Research.

Authors:  Tedros Bezabeh; Omkar B Ijare; Alexander E Nikulin; Rajmund L Somorjai; Ian Cp Smith
Journal:  Magn Reson Insights       Date:  2014-02-13

9.  Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.

Authors:  A Latifoltojar; N Dikaios; A Ridout; C Moore; R Illing; A Kirkham; S Taylor; S Halligan; D Atkinson; C Allen; M Emberton; S Punwani
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

10.  New prospects for PET in prostate cancer imaging: a physicist's viewpoint.

Authors:  Maurizio Conti
Journal:  EJNMMI Phys       Date:  2014-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.